New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America - E-Book
Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways.
1111873005
New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America - E-Book
Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways.
99.0 In Stock
New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America - E-Book

New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America - E-Book

by Franco Muggia
New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America - E-Book

New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America - E-Book

by Franco Muggia

eBook

$99.00 

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers


Overview

Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways.

Product Details

ISBN-13: 9781455744084
Publisher: Elsevier Health Sciences
Publication date: 05/08/2012
Series: Clinics: Internal Medicine , #26
Sold by: Barnes & Noble
Format: eBook
Pages: 1440
File size: 4 MB
From the B&N Reads Blog

Customer Reviews